July 21, 2003

For Immediate Release

Peripheral Vascular and Non-Vascular Stenting Markets Continue Double-Digit Growth, According to Report from MedMarket Diligence.

FOOTHILL RANCH, CA— Applications for stents – encompassing a variety endoluminal scaffolding devices – are steadily multiplying through their use in the management of many peripheral vascular and non-vascular diseases, and resulting in double-digit growth in manufacturer revenues. According to a new report from MedMarket Diligence, this growth in peripheral stents evinces their potential to fit into the interventionalist’s practice and capture caseload.

“While the less acute nature of many peripheral stent applications has been overshadowed by that of coronary stents, select peripheral applications are driving attractive market growth,” says Patrick Driscoll, President of MedMarket Diligence.  “In vascular applications, we are seeing over 15% annual growth in femoropopliteal and AAA stent revenues, and the emergence of new carotid stenting in the next year will nicely boost these numbers, while in the non-vascular area, urethral stents are taking off, pushing revenues at better than 50% annually.”

The MedMarket Diligence report on peripheral vascular and non-vascular stents is an analysis of the products, technologies, markets and companies established and actively pursuing opportunities for non-coronary stents. The report addresses the peripheral vascular applications of AAA endovascular repair, carotid artery, femoropopliteal artery, iliac artery, renal artery,  and TIPS systems; and the non-vascular areas covered include biliary, colorectal, esophageal, upper airway, ureteral and urethral stenting systems. The analysis details established and emerging products, providing a competitive analysis and market forecast over the next five years. Details on the report can be found at http://www.mediligence.com/rpt-c275.htm.

MedMarket Diligence provides tactical decision-making solutions on medical technology to the medical products and investment industries.  MedMarket Diligence publishes MedMarkets, which analyzes the market implications of new medical technology, and publishes dedicated reports on technology markets.  For more information on MedMarket Diligence, LLC, contact Patrick Driscoll at (949) 859-3401, e-mail, or visit the Web site at http://www.mediligence.com to view a sample issue of MedMarkets.